>
网站首页期刊介绍通知公告编 委 会投稿须知电子期刊广告合作联系我们
最新消息:
低剂量碘化钾治疗大鼠实验性乳腺纤维囊性增生
作者:陈伟强 许德义 
单位:东南大学基础医学院药理学教研室,江苏南京,210009
关键词:碘化钾 纤维囊性病 乳腺 大鼠 
分类号:R-332, R655.8, R914.3
出版年·卷·期(页码):2003·22·第一期(31-34)
摘要:

目的:观察低剂量碘化钾对大鼠乳腺纤维囊性增生的防治作用和对血雌激素、孕激素分泌的影响.方法:采用SD雌大鼠复制乳腺纤维囊性增生模型,低剂量碘化钾灌胃或在造模同时预防性灌胃.放射免疫方法测定给药前后血雌激素、孕激素和黄体生成素水平;用打分法评定用药前后鼠乳腺病理学改变,并与他莫昔芬的作用进行比较.结果:模型鼠给予碘化钾可减轻乳腺纤维囊性增生的病理改变,剂量依赖性地降低血雌二醇和雌三醇的水平,升高血孕酮和黄体生成素的水平,预防性给低剂量碘化钾一定程度抑制了乳腺纤维囊性增生.结论:低剂量碘化钾长期口服可能有预防和治疗乳腺纤维囊性增生的作用.

Objective  To investigate the effect of low dose of potassium iodide(KI) on fibrocystic breast disease (FBD) in modeling SD rats.Method  The fibrocystic breast disease model was established by subcutaneous injection of estradiol benzoas 0.5?mg·(kg·d)    -1   for 25 days,followed by progesterone 4?mg·(kg·d)    -1   for 5 days in female SD rats.After the model was established, the rats were divided into three groups:the model control group (treated by NS),the KI therapy groups (treated by KI 3,9 or 27?mg·(kg·d)    -1   and tamoxifen group (TAM)(treated by TAM 12?mg·(kg·d)    -1  ).The preventive therapy with KI 9?mg·(kg·d)    -1   was performed since the beginning of modeling.The therapeutic effect of KI was evaluated by pathological examination,and the serum levels of estradiol(E  2),estriol(E  3),progesterone and luteinizing hormone(LH) were determined by radioimmunoassay method.Results  After administering KI 3,9 or 27?mg·(kg·d)    -1   30?d,the pathological changes of the modeling rats were significantly abated.The serum levels of E  2 and E  3 were decreased in a dose  dependent way,whereas,the serum levels of progesterone and LH were significantly higher than those of model control rats.The production and development of fibrocystic breast were attenuated by preventive administration of KI in rats.Conclusion  KI might be used for therapy and prevention of fibrocystic breast disease.

参考文献:

[1] 左文述, 徐忠法, 刘厅. 现代乳腺肿瘤学, 1997
[2] GHENT W R. Iodine replacement in fibrocystic disease of the breast, 1993(5)
[3] 孙元琪. "乳康1号"口服液治疗乳腺小叶增生症临床分析. 浙江中西医结合杂志2000(1). doi:10.3969/j.issn.1005-4561.2000.01.012
[4] Matsuzaki T, IRAHARA M, AONO T. Physiology and action of prolactin, 1997(11)
[5] Funahashi H. Seaweed suppresses the proliferation of 7,12-dimethylbenz(a)-anthracene-induced mammary tumors in rats, 1999(9)
[6] MITTRA I. Mammotropic effect of prolactin enhanced by thyroidectomy. 1974. doi:10.1038/248525a0
[7] ESKIN B A, KROUSE T B, MODHERA P R. Etiology of mammary gland pathophysiology induced by iodine deficiency, 1985
[8] ZYCH F, MIZIA S K, MUCHA Z. Fibrocystic disease of breast and pituitary thyroid axis function, 1996(4)
[9] De Leo V, D'ANTONA D, LANZETTA D. Thyrotropin secretion before and after ovariectomy in premenopausal women. 1993(4). doi:10.3109/09513599309152513 

服务与反馈:
文章下载】【发表评论】【查看评论】【加入收藏
提示:您还未登录,请登录!点此登录
您是第 417357 位访问者


copyright ©《东南大学学报(医学版)》编辑部
联系电话:025-83272481 83272483
电子邮件:
bjb@pub.seu.edu.cn

苏ICP备09058364